Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provides project management and marketing consultancy services; and leases commercial properties. It also manufactures and markets fermentation and chemistry based active pharmaceutical ingredient; and engages in research and development activities. In addition, it is involved in power generation through co-generation plants and wind power sources. The company serves individuals, entrepreneurs, corporates, business houses, HNIs, NRIs, and pharmaceutical companies. The company was incorporated in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Pvt. Ltd.
| Current Price | ₹87.52 |
|---|---|
| Market Cap | ₹2,247 Cr |
| Sector | Real Estate > Real Estate Management and Development > Real Estate Management and Development |
| Sub-Industry | Diversified Real Estate Activities > 0 |
| P/E Ratio | 7.1 |
| Return on Equity | 13.27% |
| 52-Week Range | ₹70.46 – ₹125.54 |
| Beta (1Y) | 0.84 |
| Dividend Yield | 2.74% |
1. Active Pharmaceutical Ingredient (API)-19.4% 2. Real Estate-80.6%
Alembic Ltd. is trading at ₹87.52, with a market capitalisation of ₹2,247 Cr.
Alembic Ltd. operates in the Real Estate > Real Estate Management and Development > Real Estate Management and Development space (Diversified Real Estate Activities > 0).
Alembic Ltd. has a P/E of 7.1 and a return on equity of 13.27%.